[Clinico-immunological studies of pulmonary tuberculosis in the elderly]. 1989

S Harada, and M Takamoto, and Y Harada, and H Ninomiya, and M Maruyama, and T Ishibashi, and A Shinoda

We studied tuberculin reactivity and clinical course after starting chemotherapy in patients with active pulmonary tuberculosis divided by four age-groups less than 29, 30-49, 50-69 and 70 years and more. The skin test to tuberculin purified protein derivative (PPD) was examined in 178 cases of active pulmonary tuberculosis, 120 cases of lung cancer, 25 cases of atypical mycobacteriosis and 466 cases of the other respiratory diseases. The average size of tuberculin reaction in pulmonary tuberculosis decreased with age, but significantly higher than that in patients with other nontuberculous pulmonary diseases of the same age-group. The size of PPD skin test in the group of 70 years and more was significantly lower than other age-groups in pulmonary tuberculosis. We compared the time required for negative conversion of sputum by culture after primary chemotherapy among the different age-groups in pulmonary tuberculosis. It revealed that the time for negative conversion tended to be longer with age, and the time in the group 70 years and more was significantly longer than that of the group less than 29 years of age, although no significant differences in the radiographic severity and conditions of chemotherapy were observed. Finally, the PPD-induced lymphocyte proliferation test in vitro was done in newly diagnosed patients with pulmonary tuberculosis. The patients were divided into two groups by the size of PPD skin test (high responder more than 16 mm and low responder less than 15 mm of erythema induced by PPD).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014374 Tuberculin Test One of several skin tests to determine past or present tuberculosis infection. A purified protein derivative of the tubercle bacilli, called tuberculin, is introduced into the skin by scratch, puncture, or interdermal injection. Test, Tuberculin,Tests, Tuberculin,Tuberculin Tests
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

S Harada, and M Takamoto, and Y Harada, and H Ninomiya, and M Maruyama, and T Ishibashi, and A Shinoda
January 1991, Problemy tuberkuleza,
S Harada, and M Takamoto, and Y Harada, and H Ninomiya, and M Maruyama, and T Ishibashi, and A Shinoda
January 1993, Problemy tuberkuleza,
S Harada, and M Takamoto, and Y Harada, and H Ninomiya, and M Maruyama, and T Ishibashi, and A Shinoda
January 1986, Problemy tuberkuleza,
S Harada, and M Takamoto, and Y Harada, and H Ninomiya, and M Maruyama, and T Ishibashi, and A Shinoda
August 1983, Kekkaku : [Tuberculosis],
S Harada, and M Takamoto, and Y Harada, and H Ninomiya, and M Maruyama, and T Ishibashi, and A Shinoda
January 1970, Problemy tuberkuleza,
S Harada, and M Takamoto, and Y Harada, and H Ninomiya, and M Maruyama, and T Ishibashi, and A Shinoda
October 1989, Indian journal of medical sciences,
S Harada, and M Takamoto, and Y Harada, and H Ninomiya, and M Maruyama, and T Ishibashi, and A Shinoda
January 1967, Vestnik Akademii meditsinskikh nauk SSSR,
S Harada, and M Takamoto, and Y Harada, and H Ninomiya, and M Maruyama, and T Ishibashi, and A Shinoda
November 1980, Clinical allergy,
S Harada, and M Takamoto, and Y Harada, and H Ninomiya, and M Maruyama, and T Ishibashi, and A Shinoda
May 1990, Enfermedades infecciosas y microbiologia clinica,
S Harada, and M Takamoto, and Y Harada, and H Ninomiya, and M Maruyama, and T Ishibashi, and A Shinoda
January 1972, Problemy tuberkuleza,
Copied contents to your clipboard!